GGrantIndex
Sort

4,870 grants matching glp 1

3 UTR CONTROL OF TRA-2 TRANSLATION IN C ELEGANS

$166,609
Northwestern University · R01 · FY2000 · GM

CLINICAL PROJECT: Aging And The Pancreas

$166,367
Josephine Egan · National Institute On Aging · ZIA · FY2025 · AG

Core 2: Biospecimen

$165,975
Elisa De Stanchina · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA

Optimizing diabetes treatment strategies in complex comorbidity

$165,714
Amanda Candice Leiter · Icahn School Of Medicine At Mount Sinai · K08 · FY2024 · DK

Core D

$165,447
Joseph Avruch · Massachusetts General Hospital · P30 · FY2009 · DK

H3K9 Methylation and Pancreatic Cancer Chemoresistance

$165,209
Kebin Liu · Augusta University · R21 · FY2015 · CA

Glucagon-like peptide-1 receptor agonists in lupus

$165,000
April Jorge · Massachusetts General Hospital · R03 · FY2025 · AR

NEUROPEPTIDE Y--EFFECTS ON ENERGY METABOLISM

$164,682
University Of Minnesota Twin Cities · R01 · FY2001 · DK

Pharmacology and Pharmacometrics Core

$164,293
Kelly E. Dooley · Johns Hopkins University · P30 · FY2022 · AI

Investigating the Effects of ADGRB3 Signaling on Incretin-Mediated Insulin Secretion from Pancreatic Beta-Cells

$164,125
Sushant Bhatnagar · University Of Alabama At Birmingham · R03 · FY2023 · TR

Molecular Mechanisms of Physiologic Beta Cell Growth in Juvenile Human Pancreas

$163,876
Alvin Carter Powers · Vanderbilt University · UC4 · FY2015 · DK

Obesity induced cytokines and beta cell mass regulation

$162,963
Amelia K Linnemann · Indiana University Indianapolis · K01 · FY2017 · DK

Obesity induced cytokines and beta cell mass regulation

$162,963
Amelia K Linnemann · Indiana University Indianapolis · K01 · FY2018 · DK

The Role of Phosphodiesterase Inhibitors in Incretin Secretion

$162,665
Chee W Chia · National Institute On Aging · ZIA · FY2021 · AG

Functional Brain Imaging and Appetite-Related Hormones Pre and Post Obesity Surge

$162,600
Allan Geliebter · St. Luke'S-Roosevelt Inst For Hlth Scis · R56 · FY2008 · DK

Cardiometabolic effects of genetically decreased dipeptidyl peptidase-4 (DPP4) (Grant Transfer from UPENN)

$162,308
Jessica Rose Wilson · Mayo Clinic Jacksonville · K23 · FY2022 · HL

San Antonio OAIC - Biostatistics and Informatics Resource Core 4 (BIRC4)

$162,181
Jonathan Adam Letterman Gelfond · University Of Texas Hlth Science Center · P30 · FY2025 · AG

Pre-Clinical Vector Production Core

$162,109
William F. Goins · Brigham And Women'S Hospital · P01 · FY2018 · CA

Core--Formulation Science

$161,953
Russell J Mumper · Starpharma, Ltd · U19 · FY2006 · AI

Cardiometabolic effects of genetically decreased dipeptidyl peptidase-4 (DPP4)

$161,934
Jessica Rose Wilson · University Of Pennsylvania · K23 · FY2020 · HL

Cardiometabolic effects of genetically decreased dipeptidyl peptidase-4 (DPP4) (Grant Transfer from UPENN)

$161,934
Jessica Rose Wilson · Mayo Clinic Jacksonville · K23 · FY2023 · HL

Patient Oriented Research in Clinical Nutrition

$161,200
Thomas R Ziegler · Emory University · K24 · FY2007 · RR

Identification of Class B GPCR Modulators Using Hypersensitive Receptor Probes

$161,000
Martin Beinborn Beinborn · Tufts Medical Center · R21 · FY2008 · NS

A Graphene Nanoparticle-Based X-ray Computed Tomography Contrast Agent ForSubjects At Risk for Contrast Induced Nephropathy

$160,500
Jimmy Deon Toussaint · Theragnostic Technologies, Inc. · R43 · FY2017 · DK

Development and Commercialization of a Tau Oligomer Inhibitor for AD/RD

$160,363
James G. Moe · Oligomerix, Inc · R44 · FY2022 · AG